To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors
Clinical trial NCT06558513 · COMPLETED
Trial details
- NCT number
- NCT06558513
- Sponsor
- Evopoint Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-03
- Primary completion
- 2025-08-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.